Focus on Vaccine Development 2: How Stable is Stable? Combining biophysical techniques and advanced kinetics to support formulation development

The webinar will be focused on the use of DSC (highlighted value of extended characterization for protein engineering and stability predictions) and NTA (stated as comparable to ELISA) in the characterization and development of a stable virus vaccine .

Summary

Date:
April 21 2020 – April 21 2020
Time:
18:30 – 19:30 Arabian Standard Time
Event type:
Webinar – Live
Language:
English
Industry:
Pharmaceuticals

Speakers

Natalia Markova & Didier Clenet – Guest Speaker from Sanofi Pasteur

More information

Who should attend?

– Scientists and project leaders in academia and industry working with characterization of proteins and development of protein-based vaccines and therapeutics.

What will you learn?

– Basic principles of DSC and its application to vaccine development.

– Ways to apply DSC to characterization of recombinant multi-domain proteins

– Benefits of DSC as compared to other thermal shift techniques.

Posted By Malvern Panalytical (www.malvernpanalytical.com)
ProLab

Leave a Reply

Your email address will not be published. Required fields are marked *